Systems Biology and Systems Medicine

作者: Nathan D. Price , Lucas B. Edelman , Inyoul Lee , Hyuntae Yoo , Daehee Hwang

DOI: 10.1016/B978-0-12-382227-7.00005-7

关键词:

摘要: Abstract Systems medicine and the digital revolution are together transforming healthcare to a proactive P4 that is predictive, preventive, personalized participatory. biology—holistic, global integrative in approach—has given rise systems medicine, approach health disease. promises 1) provide deep insights into disease mechanisms, 2) make blood diagnostic window for viewing individual, 3) stratify complex diseases their distinct subtypes an impedance match against proper drugs, 4) new approaches drug target discovery 5) generate metrics assessing wellness. clinical face of has two major objectives: quantize wellness demystify Patients consumers will be driver realization through participation medically oriented social networks directed at improving own healthcare. striking implications society—including ability turn around ever-escalating costs The challenge bringing patients two-fold: first, inventing strategies technologies enable second, dealing with impact on key ethical, social, legal, regulatory, economic issues. Managing societal problems pose most significant challenges. Strategic partnerships variety types necessary bring patients.

参考文章(116)
Wei-Min Gao, Rork Kuick, Randal P Orchekowski, David E Misek, Ji Qiu, Alissa K Greenberg, William N Rom, Dean E Brenner, Gilbert S Omenn, Brian B Haab, Samir M Hanash, Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis BMC Cancer. ,vol. 5, pp. 110- 110 ,(2005) , 10.1186/1471-2407-5-110
Cory C. Funk, Shuyi Ma, Nathan D. Price, Systems approaches to molecular cancer diagnostics. Discovery Medicine. ,vol. 10, pp. 531- 542 ,(2010)
G. Ruvkun, MOLECULAR BIOLOGY: Glimpses of a Tiny RNA World Science. ,vol. 294, pp. 797- 799 ,(2001) , 10.1126/SCIENCE.1066315
Jennifer Fisher Wilson, The rocky road to useful cancer biomarkers. Annals of Internal Medicine. ,vol. 144, pp. 945- 948 ,(2006) , 10.7326/0003-4819-144-12-200606200-00022
Lucas B. Edelman, James A. Eddy, Nathan D. Price, In silico models of cancer. Wiley Interdisciplinary Reviews: Systems Biology and Medicine. ,vol. 2, pp. 438- 459 ,(2010) , 10.1002/WSBM.75
Christoph Gille, Christian Bölling, Andreas Hoppe, Sascha Bulik, Sabrina Hoffmann, Katrin Hübner, Anja Karlstädt, Ramanan Ganeshan, Matthias König, Kristian Rother, Michael Weidlich, Jörn Behre, Herrmann‐Georg Holzhütter, HepatoNet1: a comprehensive metabolic reconstruction of the human hepatocyte for the analysis of liver physiology Molecular Systems Biology. ,vol. 6, pp. 411- 411 ,(2010) , 10.1038/MSB.2010.62
Adam S. Adler, Howard Y. Chang, From description to causality: mechanisms of gene expression signatures in cancer. Cell Cycle. ,vol. 5, pp. 1148- 1151 ,(2006) , 10.4161/CC.5.11.2798
Anna V. Ivshina, Joshy George, Oleg Senko, Benjamin Mow, Thomas C. Putti, Johanna Smeds, Thomas Lindahl, Yudi Pawitan, Per Hall, Hans Nordgren, John E.L. Wong, Edison T. Liu, Jonas Bergh, Vladimir A. Kuznetsov, Lance D. Miller, Genetic Reclassification of Histologic Grade Delineates New Clinical Subtypes of Breast Cancer Cancer Research. ,vol. 66, pp. 10292- 10301 ,(2006) , 10.1158/0008-5472.CAN-05-4414
E. Moussay, K. Wang, J.-H. Cho, K. van Moer, S. Pierson, J. Paggetti, P. V. Nazarov, V. Palissot, L. E. Hood, G. Berchem, D. J. Galas, MicroRNA as biomarkers and regulators in B-cell chronic lymphocytic leukemia Proceedings of the National Academy of Sciences of the United States of America. ,vol. 108, pp. 6573- 6578 ,(2011) , 10.1073/PNAS.1019557108